Mitochondria: a target for cancer therapy

被引:203
|
作者
Armstrong, JS [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Med, Dept Biochem, Singapore 117597, Singapore
关键词
mitochondria; apoptosis; Bcl-2; Bax; BH3; domain; cancer; mitochondrial membrane permeabilization; mitochondrial permeability transition; reactive oxygen species; cyclosporine A; mitochondrial membrane potential;
D O I
10.1038/sj.bjp.0706556
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mitochondria, the cells powerhouses, are essential for maintaining cell life, and they also play a major role in regulating cell death, which occurs upon permeabilization of their membranes. Once mitochondrial membrane permeabilization (MMP) occurs, cells die either by apoptosis or necrosis. Key factors regulating MMP include calcium, the cellular redox status ( including levels of reactive oxygen species) and the mobilization and targeting to mitochondria of Bcl-2 family members. Contemporary approaches to targeting mitochondria in cancer therapy use strategies that either modulate the action of Bcl-2 family members at the mitochondrial outer membrane or use specific agents that target the mitochondrial inner membrane and the mitochondrial permeability transition (PT) pore. The aim of this review is to describe the major mechanisms regulating MMP and to discuss, with examples, mitochondrial targeting strategies for potential use in cancer therapy.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 50 条
  • [21] Mitochondria: A target for bacteria
    Lobet, Elodie
    Letesson, Jean-Jacques
    Arnould, Thierry
    BIOCHEMICAL PHARMACOLOGY, 2015, 94 (03) : 173 - 185
  • [22] Mitochondria as a Target in Treatment
    Frantz, Marie-Celine
    Wipf, Peter
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2010, 51 (05) : 462 - 475
  • [23] Is human cytomegalovirus a target in cancer therapy?
    Johnsen, John Inge
    Baryawno, Ninib
    Soderberg-Naucler, Cecilia
    ONCOTARGET, 2011, 2 (12) : 1329 - 1338
  • [24] Mitochondria and the hallmarks of cancer
    Giampazolias, Evangelos
    Tait, Stephen W. G.
    FEBS JOURNAL, 2016, 283 (05) : 803 - 814
  • [25] Mitochondria targeted fluorogenic theranostic agents for cancer therapy
    Singh, Hardev
    Sareen, Divya
    George, Jiya Mary
    Bhardwaj, Vineet
    Rha, Saehee
    Lee, Suk Joong
    Sharma, Sheetal
    Sharma, Amit
    Kim, Jong Seung
    COORDINATION CHEMISTRY REVIEWS, 2022, 452
  • [26] Novel Mitochondria-targeted Drugs for Cancer Therapy
    Fialova, Jindriska Leischner
    Raudenska, Martina
    Jakubek, Milan
    Kejik, Zdenek
    Martasek, Pavel
    Babula, Petr
    Matkowski, Adam
    Filipensky, Petr
    Masarik, Michal
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (07) : 816 - 832
  • [27] Targeting p53 to mitochondria for cancer therapy
    Galluzzi, Lorenzo
    Morselli, Eugenia
    Kepp, Oliver
    Tajeddine, Nicolas
    Kroemer, Guido
    CELL CYCLE, 2008, 7 (13) : 1949 - 1955
  • [28] Signaling From Lysosomes Enhances Mitochondria-Mediated Photodynamic Therapy In Cancer Cells
    Quiogue, Geraldine
    Saggu, Shalini
    Hung, Hsin-, I
    Kenney, Malcolm E.
    Oleinick, Nancy L.
    Lemasters, John J.
    Nieminen, Anna-Liisa
    12TH WORLD CONGRESS OF THE INTERNATIONAL PHOTODYNAMIC ASSOCIATION: PHOTODYNAMIC THERAPY: BACK TO THE FUTURE, 2009, 7380
  • [29] Mitochondria in colorectal cancer stem cells- a target in drug resistance
    Rainho, Mateus de Almeida
    Siqueira, Priscyanne Barreto
    de Amorim, Isis Salviano Soares
    Mencalha, Andre Luiz
    Thole, Alessandra Alves
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 273 - 283
  • [30] The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
    Jendrossek, Verena
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (08) : 1426 - 1438